Synthetic Biology: Who Will Emerge as the Winner?
The 21st century is the century of biology. Synthetic biology is believed to be a ‘World Changing’ industry. But the potential risks like cost control and commercialization pathways are fatefully tied to the ups and downs of countless investment decisions and the destiny of the many new start-ups getting involved. We look forward to seeing an emerging ‘giant’ on the horizon of this exciting industry.
Jun 27, 2022 12:38 PM
SMEC Obtained IPO Approval from SSE Listing Committee
Shaoxing Semiconductor Manufacturing Corporation (SMEC) (Chinese: 中芯集成) obtained IPO approval at the listing committee meeting of the SSE Science and Technology Board on November 25. The underwriter of this IPO is Haitong Securities, which intends to raise CNY 12.5 billion (USD 1.75 billion).
Yesterday 03:21 PM
Industry Watch: Chinese Cosmetic Brands In Japan (II)
Nov 25, 2022 05:49 PM
Immunotherapy in China: A Rising Star in the Field of Cancer Treatment
Nov 24, 2022 06:29 PM
Challenges and Opportunities Possessed by Digital Therapeutics Industry
Nov 23, 2022 03:23 PM